BioSpace News Archive

Pharm Country

Early Detection Remains Crucial in the Fight Against Colorectal Cancer

Olympus, a global technology leader in endoscopy, offers a reminder about the importance of screening for colorectal cancer, which may be preventable and treatable when found early.

March 8, 2022
·
5 min read
In-Vitro Fertilization Market Growth – at a CAGR of 9.1% During Forecast Period 2020-2028

Rising prevalence of both male and female infertility and rapid growth in the female working population are among the key factors driving the global market revenue growth.

March 8, 2022
·
7 min read
Cell and Gene Therapy Market Growth – at a CAGR of 19.8% During Forecast Period 2019-2027

Technological advancements in cellular and molecular biology, high prevalence of chronic and rare diseases, and increasing investments in research and development activities are some key factors expected to drive global market growth.

March 8, 2022
·
6 min read
Companion Diagnostics Market Growth – at a CAGR of 18.3% During Forecast Period 2020-2028

Rising demand for advanced therapies, increasing number of diagnostic laboratories, and high focus on co-development of drugs and diagnostic techniques are some key factors expected to drive global market revenue growth.

March 8, 2022
·
6 min read
Cancer Biomarker Market Size to Reach USD 50.19 Billion in 2030, Says Reports and Data

Rise in number of cancer patients has led to rise in investments from government to establish specialized hospitals, which is expected to drive market revenue growth.

March 8, 2022
·
9 min read
Pharm Country

OccamzRazor announces closing of $6.1M financing round to launch their AI-enabled discovery pipeline and advance preclinical development in Parkinson’s.

OccamzRazor is on a mission to create the first curative treatments for complex brain-aging diseases, such as Parkinson’s disease.

March 8, 2022
·
2 min read
Drug Development

Palleon Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of Lead Glyco-Immunology Drug Candidate for Oncology

Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today announced dosing of the first patient in the company’s Phase 1/2 study of E-602 in patients with advanced cancers.

March 8, 2022
·
3 min read
Psilera and USF Collaborators at Morsani College of Medicine Receive Additional Funding to Support Preclinical Studies on New Chemical Entities

Psilera Inc. was granted more than $130,000 from the Florida High Tech Corridor’s Matching Grants Research Program, effectively doubling the life of a study conducted in collaboration with researchers from the University of South Florida (“USF”).

March 8, 2022
·
3 min read
Biotech Bay

Guardant Health Receives Medicare Coverage for Guardant360 TissueNext™ Test

Guardant Health, Inc., a leading precision oncology company, announced that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program, has conveyed coverage for Guardant360 TissueNext™ under the existing local coverage determination .

March 8, 2022
·
3 min read
Business

Panbela Schedules Conference Call on March 24, 2022, to Report 2021 Fourth Quarter Financial Results

Panbela Therapeutics, Inc. today announced that it will host a conference call on March 24, 2022 at 4:30 PM Eastern Time to discuss results for its fourth quarter ended December 31, 2021.

March 8, 2022
·
5 min read